Mon.Dec 05, 2022

article thumbnail

TherapeuticsMD to offload drugs to Australia’s Mayne after failed buyout

Bio Pharma Dive

After a private equity takeover unraveled this summer, the women’s health company is selling its drug portfolio to Mayne Pharma in a $153 million deal

Drugs 261
article thumbnail

Sanofi and Queensland collaborate to build $190m research facility

Pharmaceutical Technology

Sanofi has signed an agreement with the Queensland Government in Australia to establish a $190m (A$280m) research facility in Brisbane. With the establishment of this Translational Science Hub, Queensland is set to become an international messenger ribonucleic acid (mRNA) vaccine hub.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Novartis prostate cancer drug succeeds in study key to company’s sales hopes

Bio Pharma Dive

The positive results could help Novartis secure approval for earlier use of the radiopharmaceutical drug Pluvicto, potentially broadening the number of eligible patients by several times the current market

Sales 241
article thumbnail

Cannabinoids receptors: popular preclinical target but banned in 137 countries

Pharmaceutical Technology

Cannabinoid receptors are a popular therapeutic target for cannabinoid-based drugs in the treatment of pain, neurological disorders and inflammation, according to GlobalData’s Pharma Intelligence Centre Drugs database.

article thumbnail

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

article thumbnail

We must improve diversity in clinical trials. These 5 steps will help.

Bio Pharma Dive

The pandemic shined a light on the importance of diversity in clinical trials. Syneos Health can help your team devise a diversity strategy

article thumbnail

Lupkynis approved for the treatment of LN in the EU and UK

Pharmaceutical Technology

On September 19, Lupkynis (voclosporin), a therapy for lupus nephritis (LN), received European Commission (EC) approval, becoming the second therapy approved in the EU for the treatment of LN after Benlysta (belimumab) from GlaxoSmithKline.

More Trending

article thumbnail

AstraZeneca’s IT hiring activity declines 3.1% in November 2022

Pharmaceutical Technology

UK-based company AstraZeneca’s IT hiring declined 3.1% in November 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity increased by 2.15% in November 2022 when compared with October 2022.

article thumbnail

How a government biologist with the USDA built her community — and her career — at Regis University

Bio Pharma Dive

When Talisa Puentes-Ortega got the chance to advance her career by going back to school, Regis provided more than an environmental biology degree — it was the foundation of a community that continues to support her

208
208
article thumbnail

Eurofins Scientific’s IT hiring activity declines 10.6% in November 2022

Pharmaceutical Technology

Luxembourg-based company Eurofins Scientific’s IT hiring declined 10.6% in November 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity declined by 10.33% in November 2022 when compared with October 2022.

article thumbnail

With new data, Nkarta builds case for ‘natural killer’ cell therapy

Bio Pharma Dive

The updated study results add to evidence that such therapies may help treat B-cell lymphomas. But it’s still unclear how long their effects could last

172
172
article thumbnail

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

article thumbnail

MerckInc’s IT hiring activity declines 8.6% in November 2022

Pharmaceutical Technology

US-based company MerckInc’s IT hiring declined 8.6% in November 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity declined by 13.09% in November 2022 when compared with October 2022.

article thumbnail

J&J drops out of hunt for Horizon, leaving Sanofi and Amgen to bid

Bio Pharma Dive

The two remaining suitors said they would make cash bids if they move forward with offers, for which they must declare “firm intent” by Jan. 10 under Irish takeover rules

138
138
article thumbnail

Parexel International’s IT hiring activity declines 3.0% in November 2022

Pharmaceutical Technology

US-based company Parexel International’s IT hiring declined 3.0% in November 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity declined by 9.68% in November 2022 when compared with October 2022.

Scientist 130
article thumbnail

Third Circuit Court of Appeals Upends “Intended Loss”

The FDA Law Blog

By Douglas B. Farquhar & John W.M.

article thumbnail

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

article thumbnail

Syneos Health’s IT hiring activity declines 4.2% in November 2022

Pharmaceutical Technology

US-based company Syneos Health’s IT hiring declined 4.2% in November 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity declined by 11.94% in November 2022 when compared with October 2022.

article thumbnail

FDA grants fast-track designation for Istesso’s IPF candidate

Pharma Times

The therapy has reduced inflammation and supported the remodelling of damaged bone

106
106
article thumbnail

Incyte signs partnership agreement with CMS for ruxolitinib cream

Pharmaceutical Technology

Incyte has signed a partnership and licence agreement with CMS subsidiary CMS Aesthetics to develop and market ruxolitinib cream to treat autoimmune and inflammatory dermatologic ailments in Greater China and some Southeast Asian countries.

article thumbnail

Valneva shares positive chikungunya vaccine results

Pharma Times

99% of participants retained very high neutralising antibody levels 12 months after treatment

Antibody 103
article thumbnail

TherapeuticsMD and Mayne sign product licensing agreements

Pharmaceutical Technology

Women’s healthcare company TherapeuticsMD has sign ed agreements for licensing its products to the Mayne Pharma affiliate in the US.

Licensing 130
article thumbnail

WHO/PAHO launch free digital health assistant to cut alcohol-related diseases

Pharma Phorum

A digital health assistant that can help people at risk of becoming dependent on alcohol has been launched in Belize, its first country, by the World Health Organisation (WHO) and Pan-American Health Organisation (PAHO).

article thumbnail

Spain’s pharma industry IT recruitment activity drops 9.1% in November 2022

Pharmaceutical Technology

Spain’s pharma industry registered a 9.1% drop in IT hiring activity in November 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The industry’s overall hiring is decreased by 15.22% in November 2022 when compared with October 2022. Out of the pharma industry’s total hiring activity, IT jobs claimed a 10.51% share in November 2022, recording an increase of 1.01% over the last three-month average share.

article thumbnail

AstraZeneca partner FibroGen slaps former employees with trade secret theft lawsuit

Fierce Pharma

AstraZeneca partner FibroGen slaps former employees with trade secret theft lawsuit. zbecker. Mon, 12/05/2022 - 10:31

91
article thumbnail

UK pharma industry IT recruitment activity drops 25.9% in November 2022

Pharmaceutical Technology

The UK’s pharma industry registered a 25.9% drop in IT hiring activity in November 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The industry’s overall hiring is decreased by 36.99% in November 2022 when compared with October 2022. Out of the pharma industry’s total hiring activity, IT jobs claimed a 1.37% share in November 2022, recording a decrease of 1.1% over the last three-month average share.

article thumbnail

SABCS: Lilly aims Verzenio at broader post-surgery breast cancer nod as Novartis' rival draws near. Will FDA bite?

Fierce Pharma

SABCS: Lilly aims Verzenio at broader post-surgery breast cancer nod as Novartis' rival draws near. Will FDA bite? Mon, 12/05/2022 - 15:10

83
article thumbnail

Switzerland’s pharma industry IT recruitment activity drops 25.4% in November 2022

Pharmaceutical Technology

Switzerland’s pharma industry registered a 25.4% drop in IT hiring activity in November 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The industry’s overall hiring is decreased by 19.13% in November 2022 when compared with October 2022. Out of the pharma industry’s total hiring activity, IT jobs claimed a 2.94% share in November 2022, recording a decrease of 0.13% over the last three-month average share.

article thumbnail

Valneva eyes first place in chikungunya vaccine race

Pharma Phorum

Valneva has moved a step closer to its goal of becoming the first company to file for approval of a vaccine against chikungunya virus in the US after reporting new clinical data today.

article thumbnail

US pharma industry IT recruitment activity drops 15.6% in November 2022

Pharmaceutical Technology

The US’s pharma industry registered a 15.6% drop in IT hiring activity in November 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The industry’s overall hiring is decreased by 11.32% in November 2022 when compared with October 2022. Out of the pharma industry’s total hiring activity, IT jobs claimed a 1.57% share in November 2022, recording a decrease of 0.17% over the last three-month average share.

article thumbnail

In free fall, Clovis defaults on loan and agrees to further restrict Rubraca use

Fierce Pharma

In free fall, Clovis defaults on loan and agrees to further restrict Rubraca use. kdunleavy. Mon, 12/05/2022 - 09:34

83
article thumbnail

PureTech Reveals New CBD Pill to Rival Jazz’s Epidiolex

XTalks

Clinical-stage biotech company PureTech Health has announced it has developed a new oral CBD therapeutic candidate with improved bioavailability and tolerability, which could expand use of the CBD prodrug in a wide range of indications and age groups.

article thumbnail

New Nkarta data backs up natural killer approach to cancer treatment

Pharma Phorum

Harnessing the power of natural killer (NK) cells to attack cancer is as-yet an unproven strategy in oncology – but one that is garnering increased interest as clinical trials start to generate data.

article thumbnail

Progress Flickers in Women’s Healthcare as Femtech Builds Traction

BioSpace

The worldwide market for therapeutics designed specifically for conditions and diseases that affect mainly women is expected to exceed $65 billion by 2027. BioSpace looks at three femtech leaders

article thumbnail

WuXi STA Unveils New Parenteral Formulation Manufacturing Line

Pharmaceutical Commerce

Will further boost CDMO’s injectable drug product platform.

article thumbnail

MEI Abandons PI3K Inhibitor, 30% of Staff in Strategic Shift

BioSpace

MEI Pharma, Inc. will have a strategic realignment that would see at least 30% of its workforce laid off and a pivot towards two of its earlier clinical-stage assets

70
article thumbnail

Novartis’ Pluvicto presents survival benefit for castration-resistant prostate cancer

Pharma Phorum

It has been announced today that Novartis’ Pluvicto (lutetium vipivotide tetraxetan) has shown statistically significant and clinically meaningful radiographic progression-free survival benefit in patients with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC).